期刊文献+

棓丙酯注射液对高脂血症大鼠血脂代谢影响 被引量:2

Effect of propylgallate Injection on experimental hyperlipidemia in rats
原文传递
导出
摘要 【目的】探讨棓丙酯注射液对高脂血症大鼠的血脂调节作用。【方法】棓丙酯注射液13、26、52 mg.(kg.d)-1给大鼠连续腹腔注射4周,测定大鼠体重和血清总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)的含量,同时对大鼠进行肝功能检查。【结果】棓丙酯注射液能明显降低实验性高脂血症大鼠TC、TG、LDL-C及过氧化脂质(LPO)含量,明显提高HDL-C含量及超氧化物歧化酶(SOD)活性。【结论】棓丙酯注射液对高脂血症大鼠降血脂作用明显,能有效调节机体脂质代谢,对治疗高脂血症有一定的作用。 [Objective] To explore the effect of propylgallate injection on experimental hyperlipidemia in rats. [Methods] Hyperlipemia rats were given propylgallatc injection 13, 26, 52 mg. (kg. d)^-1 respectively by intraperitoneal injection, for 4 weeks.Body weight,serum level of total cholesterol (TC),triglyceride (TG),low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), and liver function were measured at the end of the experiment. [ Results] TC, TG, LDL-C and lipidperoxidatio (LPO) contents were signifieandy decreased,and HDL-C contents and superoxidedismutas (SOD)activity were significantly increased. [ Conclusion ] Propylgallate injection can regulate lipid metabolism effectively,treat hyperlipidemia definitely.
出处 《武警后勤学院学报(医学版)》 CAS 2013年第4期267-269,共3页 Journal of Logistics University of PAP(Medical Sciences)
关键词 棓丙酯 高脂血症 大鼠 Propylgallate Hyperlipidemia Rats
  • 相关文献

参考文献7

二级参考文献20

  • 1莫晓燕,黄海霞,洪喻,耿涛,张振强,杜晓阳.赤芍总苷对培养乳鼠心肌细胞损伤的抗氧化作用[J].中国药理学通报,2004,20(10):1119-1121. 被引量:22
  • 2咸红.降血脂药的研究进展及安全性评估[J].首都医药,2005,12(24):37-38. 被引量:3
  • 3郭姣,唐春萍,陈宝田,陈红红,胡旭光.不同提取工艺的调脂康对血脂异常大鼠模型的调脂作用研究[J].中国实验方剂学杂志,2006,12(6):62-63. 被引量:7
  • 4沈宁,贺蓓.中年时期肥胖或超重均可增加死亡风险[J].中华医学杂志,2006,86(37):2610-2610. 被引量:9
  • 5VERGOULASG, MISERLISG, SOLONAKIF. Combined treatment of hypercholesterolemia of renal transplant allografi recipients with fluvastatin and gemfibrozil. Transpl Int ,2000,13 ( 1 ) :64-67.
  • 6Pieper JA. Overview of niacin formulations:differences in pharmacyokinetics, efficacy and safety. Am J Health Syst Pharm,2003,60 ( 13Suppl2 ) :9.
  • 7MeaS T, Cimadevilla C,Timsit J, et al. Elevation of CKP induced by ezetimibe in monotherapy, reportnn two eases. Diabetes Metab, 2006,32 (4) : 364 -366.
  • 8Najib J. Fenoflbrate in the treatment of dyslipidemia, a review of the data as they relate to the new suprabioavailable tablet formulation. Clin Ther,2006,24 ( 12 ) :2022-2050.
  • 9Medina J,Fernandez-Salazar LI,Garcia-Buey L,et al.Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis[J].Diabetes Care,2004,27:2057-2066.
  • 10Perry IJ,Wannamethee SO,Shaper AG.Prospective study of serum gamma glutamyl transferase and risk of NIDDM[J].Diabetes Care,1998,21:732-737.

共引文献191

同被引文献13

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部